NEW YORK (GenomeWeb News) – Indian biotech services company Jubilant Biosys has entered a co-marketing agreement with DiscoveRx to screen potential drug compounds, Jubilant said yesterday.
The agreement will enable Jubilant’s pharmaceutical customers to use DiscoveRx services such as the PathHunter and CampHunter cell lines and chemiluminescent detection technology.
The agreement will also allow DiscoveRx to offer screening solutions from India, Jubilant said.
Jubilant Biosys, based in Noida with facilities in Bangalore, is a subsidiary of Jubilant Organsys.